Back to Agenda
SLS04 Scientific Benefit-Risk Management and Communication for the Future
Session Chair(s)
Mamoru Narukawa, PhD, RPh
Professor,Graduate School of Pharmaceutical Sciences
Kitasato University, Japan
Scientific Benefit Risk Management and Benefit Risk Communication for the Future
Speaker(s)
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Juan Garcia-Burgos, MD, PhD
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
Kazuhiko Ishida, MSc, RPh
Astellas Pharma Inc., Japan
Director, Pharmacovigilance
Have an account?